Skip to Content

CL8 3 mg (Rivastigmine Tartrate 3 mg)

Pill with imprint CL8 3 mg is Orange, Capsule-shape and has been identified as Rivastigmine Tartrate 3 mg. It is supplied by Macleods Pharmaceuticals Limited.

Rivastigmine is used in the treatment of alzheimer's disease; lewy body dementia; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 3 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CL8 3 mg

Rivastigmine tartrate 3 mg CL8 3 mg

Rivastigmine Tartrate

Imprint:
CL8 3 mg
Strength:
3 mg
Color:
Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinesterase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Macleods Pharmaceuticals Limited
National Drug Code (NDC):
33342-0090

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide